Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

被引：1

作者：

Shenghua Gao ^{[1
]}

Tianguang Huang ^{[1
]}

Letian Song ^{[1
]}

Shujing Xu ^{[1
]}

Yusen Cheng ^{[1
]}

Srinivasulu Cherukupalli ^{[1
]}

Dongwei Kang ^{[1
,2
]}

Tong Zhao ^{[1
]}

Lin Sun ^{[1
]}

Jian Zhang ^{[1
]}

Peng Zhan ^{[1
,2
]}

Xinyong Liu ^{[1
,2
]}

机构：

[1] Department of Medicinal Chemistry,Key Laboratory of Chemical Biology,Ministry of Education,School of Pharmaceutical Sciences,Cheeloo College of Medicine,Shandong University

[2] China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province

来源：

Acta Pharmaceutica Sinica B | 2022年 / 12卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel therapies are urgently needed to improve global treatment of SARS-CoV-2 infection.Herein, we briefly provide a concise report on the medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors with representative examples in different strategies from the medicinal chemistry perspective.

引用

页码：581 / 599

页数：19

共 50 条

[1] Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Gao, Shenghua
Huang, Tianguang
Song, Letian
Xu, Shujing
Cheng, Yusen
Cherukupalli, Srinivasulu
Kang, Dongwei
Zhao, Tong
Sun, Lin
Zhang, Jian
Zhan, Peng
Liu, Xinyong
ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 581 - 599
[2] Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 M inhibitors
Letian Song
Shenghua Gao
Bing Ye
Mianling Yang
Yusen Cheng
Dongwei Kang
Fan Yi
JinPeng Sun
Luis MenndezArias
Johan Neyts
Xinyong Liu
Peng Zhan
Acta Pharmaceutica Sinica B, 2024, 14 (01)
[3] Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Song, Letian
Gao, Shenghua
Ye, Bing
Yang, Mianling
Cheng, Yusen
Kang, Dongwei
Yi, Fan
Sun, Jin-Peng
Menendez-Arias, Luis
Neyts, Johan
Liu, Xinyong
Zhan, Peng
ACTA PHARMACEUTICA SINICA B, 2024, 14 (01) : 87 - 109
[4] SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research
Rocha, Weslany Souza
Zhan, Peng
da Silva-Junior, Edeildo Ferreira
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (17) : 1625 - 1639
[5] Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors
Fouedjou, Romuald Tematio
Chtita, Samir
Bakhouch, Mohamed
Belaidi, Salah
Ouassaf, Mebarka
Djoumbissie, Loris Alvine
Tapondjou, Leon Azefack
Qais, Faizan Abul
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (19): : 8615 - 8629
[6] Advances in the Development of SARS-CoV-2 Mpro Inhibitors
Agost-Beltran, Laura
de la Hoz-Rodriguez, Sergio
Bou-Iserte, Lledo
Rodriguez, Santiago
Fernandez-de-la-Pradilla, Adrian
Gonzalez, Florenci V.
MOLECULES, 2022, 27 (08):
[7] Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
Schuller, Marion
Zarganes-Tzitzikas, Tryfon
Bennett, James
De Cesco, Stephane
Fearon, Daren
von Delft, Frank
Fedorov, Oleg
Brennan, Paul E. E.
Ahel, Ivan
PATHOGENS, 2023, 12 (02):
[8] SARS-CoV-2 neutralizing antibody development strategies
Balcioglu, Bertan Koray
Oncu, Melis Denizci
Ozturk, Hasan Umit
Yucel, Fatima
Kaya, Filiz
Serhatli, Muge
Polat, Hivda Ulbegi
Tekin, Saban
Bahadir, Aylin Ozdemir
TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 203 - 214
[9] Medicinal Chemistry of Antisense Oligonucleotides for Therapeutic Use in SARS-CoV-2: Design Strategies and Challenges for Targeted Delivery
Nedaeinia, Reza
Ranjbar, Maryam
Goli, Mohammad
Etebari, Mahmoud
Safabakhsh, Saied
Bayram, Hasan
Ferns, Gordon A.
Tehrani, Helena Moradiyan
Salehi, Rasoul
CURRENT MEDICINAL CHEMISTRY, 2025, 32 (06) : 1144 - 1167
[10] Screening Asian Medicinal Plants for SARS-CoV-2 Inhibitors: A Computational Approach
Khalid, Hira
Ahmad, Iqra
Sarfraz, Asifa
Iqbal, Anwar
Nishan, Umar
Dib, Hanna
Ullah, Riaz
Sheheryar, Sheheryar
Shah, Mohibullah
CHEMISTRY & BIODIVERSITY, 2025,

← 1 2 3 4 5 →